To determine what proportion of patients have inferior angle recess dimensions that could accommodate the OTX-TIC, and what are risk factors for implant contact with the corneal endothelium.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Primary Outcome 1
Timeframe: 4-6 Months
Primary Outcome 2
Timeframe: 4-6 Months
Primary Outcome 3
Timeframe: 4-6 Months
Primary Outcome 4
Timeframe: 4-6 Months